Raymond James & Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $46.7M | Sell |
|
|||||
|
2024
Q2 | $44.9M | Sell |
|
|||||
|
2024
Q1 | $50.9M | Buy |
|
|||||
|
2023
Q4 | $41.7M | Sell |
|
|||||
|
2023
Q3 | $41.3M | Sell |
|
|||||
|
2023
Q2 | $40.9M | Buy |
|
|||||
|
2023
Q1 | $40.1M | Buy |
|
|||||
|
2022
Q4 | $36.8M | Sell |
|
|||||
|
2022
Q3 | $31.6M | Sell |
|
|||||
|
2022
Q2 | $65.4M | Buy |
|
|||||
|
2022
Q1 | $61.2M | Buy |
|
|||||
|
2021
Q4 | $59.9M | Sell |
|
|||||
|
2021
Q3 | $52.8M | Sell |
|
|||||
|
2021
Q2 | $56.9M | Buy |
|
|||||
|
2021
Q1 | $48.8M | Sell |
|
|||||
|
2020
Q4 | $56M | Sell |
|
|||||
|
2020
Q3 | $98.3M | Sell |
|
|||||
|
2020
Q2 | $118M | Sell |
|
|||||
|
2020
Q1 | $124M | Sell |
|
|||||
|
2019
Q4 | $165M | Buy |
|
|||||
|
2019
Q3 | $147M | Sell |
|
|||||
|
2019
Q2 | $144M | Sell |
|
|||||
|
2019
Q1 | $155M | Sell |
|
|||||
|
2018
Q4 | $145M | Sell |
|
|||||
|
2018
Q3 | $166M | Sell |
|
|||||
|
2018
Q2 | $169M | Sell |
|
|||||
|
2018
Q1 | $169M | Buy |
|
|||||
|
2017
Q4 | $139M | Sell |
|
|||||
|
2017
Q3 | $174M | Buy |
|
|||||
|
2017
Q2 | $154M | Buy |
|
|||||
|
2017
Q1 | $136M | Buy |
|
|||||
|
2016
Q4 | $113M | Sell |
|
|||||
|
2016
Q3 | $154M | Buy |
|
|||||
|
2016
Q2 | $144M | Buy |
|
|||||
|
2016
Q1 | $125M | Buy |
|
|||||
|
2015
Q4 | $110M | Sell |
|
|||||
|
2015
Q3 | $109M | Sell |
|
|||||
|
2015
Q2 | $120M | Buy |
|
|||||
|
2015
Q1 | $111M | Buy |
|
|||||
|
2014
Q4 | $85.4M | Buy |
|
|||||
|
2014
Q3 | $84.8M | Buy |
|
|||||
|
2014
Q2 | $66.3M | Buy |
|
|||||
|
2014
Q1 | $54.9M | Buy |
|
|||||
|
2013
Q4 | $49.6M | Buy |
|
|||||
|
2013
Q3 | $43.5M | Buy |
|
|||||
|
2013
Q2 | $40.3M | Buy |
|